Project Grant DP2CA290967
Award Date
9/22/23
Completion Date
8/31/26
Dollars Obligated
$1.4M
Funding Federal Agency
Office of the Director
Awarding Federal Agency
National Cancer Institute
Federal Grant Program
93.310
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under CFDA Program 93.310 - Trans-NIH Research Support, provides $1,476,000.00 to The University of Texas Southwestern Medical Center to develop and apply innovative tools to study the role of subcellular redox circuits in tumor metastasis. The project aims to address key questions about how highly metastatic tumors overcome oxidative stress, using advanced in vivo optogenetic approaches,...
The University of Texas Southwestern Medical Center (UT Southwestern) has been awarded a Project Grant for $1,180,962.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on June 30, 2024, will support a research project titled "TUMOR SURFACE BIOMARKER-INDEPENDENT TARGETING OF KIDNEY CANCER TO IMPROVE IMMUNOTHERAPY" over a performance period ending on June 29, 2027. The grant funding will enable UT...
The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $1,107,000 project grant from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on tumor extravasation in zebrafish as a prognostic marker and therapeutic target for kidney cancer metastasis. The 3-year grant, which began on September 1, 2023 and runs through August 31, 2026, will support basic, applied, and advanced biomedical research with the...
The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $766,965 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) on June 30, 2024. The grant supports a 3-year research project to develop new methods for targeting kidney cancer tumors in order to improve immunotherapy outcomes. The research aims to identify tumor surface biomarkers that can be leveraged to enhance the effectiveness of cancer...
The University of Texas Southwestern Medical Center was awarded a $574,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The 5-year grant, effective May 1, 2025 through February 28, 2030, will support the center's research on understanding the general principles of receptor tyrosine kinase (RTK) signaling through structural and functional studies. The research aims to elucidate how...
The University of Texas Southwestern Medical Center has been awarded a $432,326 Project Grant by the National Cancer Institute (NCI) under the Cancer Research Manpower (CFDA 93.398) federal grant program. This 5-year grant supports the Translational Cancer Biology (TCB) T32 Training Program, which will provide funding for 2 pre-doctoral and 4 post-doctoral trainees to conduct bench-to-bedside cancer research. The program aims to train high-quality cancer researchers with the intellectual,...
The University of Texas Southwestern Medical Center was awarded a $651,001 Project Grant by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The funding supports research to advance the understanding of the structural and biochemical mechanisms underlying microtubule dynamics and regulation. The research aims to reveal the allosteric logic of the tubulin conformation cycle, provide new biochemical insights...
The University of Texas Southwestern Medical Center was awarded a $984,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Ribosome Marylation and Stress Responses in Ovarian Cancer: New Therapeutic Opportunities". The 3-year grant, effective September 1, 2024, will support basic science, translational, and clinical research to investigate new treatment approaches for ovarian cancer. As a...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $1,107,000 three-year Project Grant to The University of Texas Southwestern Medical Center in Dallas, TX. The grant, effective September 1, 2023, will fund research to characterize the epigenetic and metabolic vulnerabilities in clear cell renal cell carcinoma (ccRCC) with VHL gene deficiencies, and explore the therapeutic potential of these findings. The University of Texas System will...
The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $713,689 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The three-year grant, effective September 1, 2023, will support UT Southwestern's research to leverage biophysicochemical motifs in T-cell receptor antigen binding regions and antigen co-occurrence to predict response to immune checkpoint inhibitors. The grant provides funding for basic...